TBX4 and coronary artery disorder: The prevalence of likely pathogenic SMAD6 variants in our CHD-APAH patient cohort (6.3%) was higher than the reported frequency for SOX17 (3.2%) or TBX4 (2.6%) in CHD-APAH patients16.